{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:49Z","timestamp":1786997929765,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.vaccine.2015.06.009","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T19:57:41Z","timestamp":1434225461000},"page":"3636-3649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Risk of febrile seizure after measles\u2013mumps\u2013rubella\u2013varicella vaccine: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"33","author":[{"given":"Shu-Juan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Quan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8450-9300","authenticated-orcid":false,"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.06.009_bib0350","first-page":"113","article-title":"Concomitant administration of varicella vaccine with combined measles, mumps, and rubella vaccine in healthy children aged 12 to 24 months of age","volume":"20","author":"Stuck","year":"2002","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0355","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0360","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/0063030-200822060-00005","article-title":"Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix)","volume":"22","author":"Kreth","year":"2008","journal-title":"BioDrugs"},{"issue":"47","key":"10.1016\/j.vaccine.2015.06.009_bib0365","first-page":"1212","article-title":"Licensure of a combines live attenuated measles, mumps, rubella, and varicella vaccine","volume":"57","author":"CDC","year":"2005","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0370","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1358\/dot.2008.44.4.1210755","article-title":"A combination vaccine against measles, mumps, rubella and varicella","volume":"44","author":"Knuf","year":"2008","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0375","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.2.5.3246","article-title":"Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad)","volume":"2","author":"Kuter","year":"2006","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0380","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00148581-200810050-00007","article-title":"Live attenuated measles, mumps, rubella, and varicella zoster virus vaccine (Priorix-Tetra)","volume":"10","author":"Dhillon","year":"2008","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0385","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1016\/j.vaccine.2009.07.076","article-title":"A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra (TM)): immunogenicity and safety profile","volume":"27","author":"Hanna","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0390","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1016\/j.vaccine.2014.08.067","article-title":"Analysis of safety data in children after receiving two doses of ProQuad((R)) (MMRV)","volume":"32","author":"Klopfer","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0395","first-page":"89","article-title":"Fever: pathogenesis and treatment","volume":"vol. 1","author":"Lorin","year":"1998"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0400","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1212\/WNL.60.2.E1","article-title":"Seizures in children with fever: generally good outcome","volume":"60","author":"Jankowiak","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0405","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jamapediatrics.2013.2745","article-title":"Effect of age on the risk of fever and seizures following immunization with measles-containing vaccines in children","volume":"167","author":"Rowhani-Rahbar","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0410","first-page":"1","article-title":"Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Marin","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0415","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pcl.2005.09.010","article-title":"Seizures in children","volume":"53","author":"Friedman","year":"2006","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0420","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1528-1167.2011.03134.x","article-title":"A retrospective population-based study on seizures related to childhood vaccination","volume":"52","author":"von Spiczak","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0425","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1586\/14760584.2013.814781","article-title":"Vaccines and febrile seizures","volume":"12","author":"Principi","year":"2013","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0435","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0440","series-title":"The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2014"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0445","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/016327870102400203","article-title":"Methods for exploring heterogeneity in meta-analysis","volume":"24","author":"Song","year":"2001","journal-title":"Eval Health Prof"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0450","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0455","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0460","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0465","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0470","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0475","unstructured":"GlaxoSmithKline. GlaxoSmithKline clinical trial register: 208136 (MeMuRu-OKA). Available: http:\/\/wwwgsk-clinicalstudyregistercom\/ (accessed 16.10.14)."},{"key":"10.1016\/j.vaccine.2015.06.009_bib0480","unstructured":"Health NIo ClinicalTrials.gov, available: http:\/\/clinicaltrialsgov\/ (accessed 12.10.14)"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0485","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0490","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/01.inf.0000172901.29621.e9","article-title":"Dose\u2013response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0495","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","article-title":"Immunogenicity and safety of two doses of tetravalent measles\u2013mumps\u2013rubella\u2013varicella vaccine in healthy children","author":"Knuf","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0500","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.inf.0000220209.35074.0b","article-title":"The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children \u2013 a study of manufacturing consistency and persistence of antibody","volume":"25","author":"Lieberman","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0505","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.inf.0000207857.10947.1f","article-title":"Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate\/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines","volume":"25","author":"Shinefield","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0510","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s15010-007-6337-z","article-title":"Safety and immunogenicity of early vaccination with two doses of tetravalent measles\u2013mumps\u2013rubella\u2013varicella (MMRV) vaccine in healthy children from 9 months of age","author":"Goh","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0515","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00431-007-0506-z","author":"Zepp","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0520","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/INF.0b013e318170bb22","article-title":"Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles\u2013mumps\u2013rubella\u2013varicella vaccine in healthy children during the second year of life","author":"Schuster","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0525","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.vaccine.2009.02.044","article-title":"Safety and immunogenicity of a measles\u2013mumps\u2013rubella\u2013varicella vaccine given as a second dose in children up to six years of age","author":"Halperin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0530","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00431-010-1142-6","article-title":"Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles\u2013mumps\u2013rubella\u2013varicella vaccine to children aged 11\u201321 months","author":"Knuf","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0535","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/INF.0b013e3181dffabf","article-title":"Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles\u2013mumps\u2013rubella\u2013varicella vaccine in children aged 12 to 16 months","author":"Vesikari","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0540","doi-asserted-by":"crossref","first-page":"e1387","DOI":"10.1542\/peds.2010-2132","article-title":"Immunogenicity and safety of MMRV and PCV-7 administered concomitantly in healthy children","author":"Leonardi","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0545","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1016\/j.vaccine.2011.02.067","article-title":"Immunogenicity and safety of a measles\u2013mumps\u2013rubella\u2013varicella vaccine following a 4-week or a 12-month interval between two doses","author":"R\u00fcmke","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0550","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1016\/j.vaccine.2011.03.043","article-title":"Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles\u2013mumps\u2013rubella\u2013varicella vaccine during the second year of life: an open, randomized controlled trial","volume":"29","author":"Vesikari","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0555","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1097\/INF.0b013e318259fc8a","article-title":"Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age","volume":"31","author":"Blatter","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0560","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1016\/j.vaccine.2012.03.080","article-title":"Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers","author":"Klein","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0565","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/INF.0b013e318267fd8b","article-title":"Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albumin","volume":"31","author":"Ruger","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0570","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.vaccine.2012.02.062","article-title":"Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad (R)) in infants from 9 months of age","volume":"30","author":"Vesikari","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0575","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4161\/hv.24035","article-title":"Immunogenicity and safety of combined measles\u2013mumps\u2013rubella\u2013varicella vaccine using new measles and rubella working seeds in healthy children in Taiwan and Singapore: a phase II, randomized, double-blind trial","volume":"9","author":"Huang","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0580","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(12)61961-8","article-title":"Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials","volume":"381","author":"Vesikari","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0585","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4161\/hv.24873","article-title":"Concomitant administration of hepatitis A vaccine with measles\/mumps\/rubella\/varicella and pneumococcal vaccines in healthy 12- to 23-month-old children","volume":"9","author":"Yetman","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0590","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7774\/cevr.2014.3.1.91","article-title":"Immunogenicity and safety of a tetravalent measles\u2013mumps\u2013rubella\u2013varicella vaccine: an open-labeled, randomized trial in healthy Korean children","volume":"3","author":"Cha","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0595","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(12)61461-5","article-title":"Protection against varicella with two doses of combined measles\u2013mumps\u2013rubella\u2013varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial","volume":"383","author":"Prymula","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0600","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","article-title":"Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting","volume":"27","author":"Jacobsen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0605","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2010-0665","article-title":"Measles\u2013mumps\u2013rubella\u2013varicella combination vaccine and the risk of febrile seizures","volume":"126","author":"Klein","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0610","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1542\/peds.2011-3198","article-title":"Measles-containing vaccines and febrile seizures in children age 4 to 6 years","volume":"129","author":"Klein","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0615","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1016\/j.vaccine.2014.07.024","article-title":"The weight of MMRV-related febrile convulsions among other clinical factors contributing to febrile convulsions in children","volume":"32","author":"Gavrielov-Yusim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0620","doi-asserted-by":"crossref","first-page":"e1492","DOI":"10.1542\/peds.2013-3429","article-title":"Timely versus delayed early childhood vaccination and seizures","volume":"133","author":"Hambidge","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0625","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1503\/cmaj.140078","article-title":"Risk of febrile seizures after first dose of measles\u2013mumps\u2013rubella\u2013varicella vaccine: a population-based cohort study","volume":"186","author":"MacDonald","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0630","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.vaccine.2013.12.011","article-title":"Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination","volume":"32","author":"Schink","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0635","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.vaccine.2003.09.008","article-title":"Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation","volume":"22","author":"Bonhoeffer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0640","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0264-410X(02)00459-0","article-title":"Reactogenicity and immunogenicity of a live attenuated tetravalent measles\u2013mumps\u2013rubella\u2013varicella (MMRV) vaccine","author":"Nolan","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0645","first-page":"35","article-title":"Which child will have a febrile seizure","volume":"147","author":"Bethune","year":"1993","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0650","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"Sterne","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0655","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/473436a","article-title":"Vaccines, the real issues in vaccine safety","volume":"473","author":"Kwok","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0660","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMoa003077","article-title":"The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine","volume":"345","author":"Barlow","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0665","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.pediatrneurol.2008.02.006","article-title":"Incidence of febrile seizures in Finland: prospective population-based study","volume":"38","author":"Sillanpaa","year":"2008","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0670","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(04)00808-7","article-title":"Fever, genes, and epilepsy","volume":"3","author":"Baulac","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0675","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jclinepi.2010.08.001","article-title":"Real world research","volume":"63","author":"Knottnerus","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0680","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1542\/peds.103.6.1307","article-title":"Practice parameter: long-term treatment of the child with simple febrile seizures. American Academy of Pediatrics. Committee on Quality Improvement, Subcommittee on Febrile Seizures","volume":"103","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0685","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1016\/j.vaccine.2012.08.075","article-title":"Febrile seizures and measles\u2013mumps\u2013rubella\u2013varicella (MMRV) vaccine: what do primary care physicians think","volume":"30","author":"O\u2019Leary","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.009_bib0690","first-page":"786","article-title":"Evidence to guide measles immunization recommendations","volume":"89","author":"Endres","year":"2014","journal-title":"Am Fam Physician"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15007756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15007756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T07:11:02Z","timestamp":1556349062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15007756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":69,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0264410X15007756"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of febrile seizure after measles\u2013mumps\u2013rubella\u2013varicella vaccine: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}